EBV and other viruses as triggers of tertiary lymphoid structures in primary Sjögren’s syndrome

References

• Ramos-Casals M, Brito-Zerón P, Sisó-Almirall A, Bosch X. Primary Sjogren syndrome. BMJ 2012;344:e3821
   PubMed Web of Science ®Google Scholar
• Mavragani CP, Moutsopoulos HM. Sjögren’s Syndrome. Annu Rev Pathol Mech Dis 2014;9:273-85
   PubMed Web of Science ®Google Scholar
• Goëb V, Salle V, Duhaut P, et al. Clinical significance of autoantibodies recognizing Sjögren’s syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren’s syndrome. Clin Exp Immunol 2007;148(2):281-7
   PubMed Web of Science ®Google Scholar
• Jonsson R, Theander E, Sjöström B, et al. Autoantibodies present before symptom onset in primary Sjögren syndrome. JAMA 2013;310(17):1854-5
   PubMed Web of Science ®Google Scholar
• Theander E, Vasaitis L, Baecklund E, et al. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjogren’s syndrome. Ann Rheum Dis 2011;70(8):1363-8
   PubMed Web of Science ®Google Scholar
• Barone F, Bombardieri M, Manzo A, et al. Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren’s syndrome. Arthritis Rheum 2005;52(6):1773-84
   PubMed Web of Science ®Google Scholar
• Aloisi F, Pujol-Borrell R. Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol 2006;6(3):205-17
   PubMed Web of Science ®Google Scholar
• Neyt K, Perros F, GeurtsvanKessel CH, et al. Tertiary lymphoid organs in infection and autoimmunity. Trends Immunol 2012;33(6):297-305
   PubMed Web of Science ®Google Scholar
• Chen S-C, Vassileva G, Kinsley D, et al. Ectopic expression of the murine chemokines CCL21a and CCL21b induces the formation of lymph node-like structures in pancreas, but not skin, of transgenic mice. J Immunol 2002;168(3):1001-8
   PubMed Web of Science ®Google Scholar
• Luther SA, Bidgol A, Hargreaves DC, et al. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J Immunol 2002;169(1):424-33
   PubMed Web of Science ®Google Scholar
• Luther SA, Lopez T, Bai W, et al. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity 2000;12(5):471-81
   PubMed Web of Science ®Google Scholar
• Salomonsson S, Jonsson MV, Skarstein K, et al. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren’s syndrome. Arthritis Rheum 2003;48(11):3187-201
   PubMed Web of Science ®Google Scholar
• Manzo A, Paoletti S, Carulli M, et al. Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis. Eur J Immunol 2005;35(5):1347-59
   PubMed Web of Science ®Google Scholar
• Amft N, Curnow SJ, Scheel-Toellner D, et al. Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren’s syndrome. Arthritis Rheum 2001;44(11):2633-41
   PubMed Web of Science ®Google Scholar
• Serafini B, Rosicarelli B, Magliozzi R, et al. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol 2004;14(2):164-74
   PubMed Web of Science ®Google Scholar
• Armengol M-P, Cardoso-Schmidt CB, Fernández M, et al. Chemokines determine local lymphoneogenesis and a reduction of circulating CXCR4+ T and CCR7 B and T lymphocytes in thyroid autoimmune diseases. J Immunol 2003;170(12):6320-8
   PubMed Web of Science ®Google Scholar
• Armengol MP, Juan M, Lucas-Martín A, et al. Thyroid autoimmune disease: demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers. Am J Pathol 2001;159(3):861-73
   PubMed Web of Science ®Google Scholar
• Drayton DL, Liao S, Mounzer RH, Ruddle NH. Lymphoid organ development: from ontogeny to neogenesis. Nat Immunol 2006;7(4):344-53
   PubMed Web of Science ®Google Scholar
• Corsiero E, Bombardieri M, Manzo A, et al. Role of lymphoid chemokines in the development of functional ectopic lymphoid structures in rheumatic autoimmune diseases. Immunol Lett 2012;145(1-2):62-7
   PubMed Web of Science ®Google Scholar
• Bombardieri M, Pitzalis C. Ectopic lymphoid neogenesis and lymphoid chemokines in Sjogren’s syndrome: at the interplay between chronic inflammation, autoimmunity and lymphomagenesis. Curr Pharm Biotechnol 2012;13(10):1989-96
   PubMed Web of Science ®Google Scholar
• Link A, Vogt TK, Favre S, et al. Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nat Immunol 2007;8(11):1255-65
   PubMed Web of Science ®Google Scholar
• Carlsen HS. Disparate lymphoid chemokine expression in mice and men: no evidence of CCL21 synthesis by human high endothelial venules. Blood 2005;106(2):444-6
   PubMed Web of Science ®Google Scholar
• Linterman MA, Beaton L, Yu D, et al. IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses. J Exp Med 2010;207(2):353-63
   PubMed Web of Science ®Google Scholar
• King C, Tangye SG, Mackay CR. T Follicular Helper (T FH) Cells in Normal and Dysregulated Immune Responses. Annu Rev Immunol 2008;26(1):741-66
   PubMedGoogle Scholar
• Gunn MD, Ngo VN, Ansel KM, et al. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt’s lymphoma receptor-1. Nature 1998;391(6669):799-803
   PubMed Web of Science ®Google Scholar
• Muramatsu M, Kinoshita K, Fagarasan S, et al. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000;102(5):553-63
   PubMed Web of Science ®Google Scholar
• Barone F, Bombardieri M, Rosado MM, et al. CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjogren’s syndrome and MALT lymphoma: association with reactive and malignant areas of lymphoid organization. J Immunol 2008;180(7):5130-40
   PubMed Web of Science ®Google Scholar
• Manzo A, Vitolo B, Humby F, et al. Mature antigen-experienced T helper cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of the rheumatoid joint. Arthritis Rheum 2008;58(11):3377-87
   PubMed Web of Science ®Google Scholar
• Xanthou G, Polihronis M, Tzioufas AG, et al. “Lymphoid” chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjögren’s syndrome patients: possible participation in lymphoid structure formation. Arthritis Rheum 2001;44(2):408-18
   PubMed Web of Science ®Google Scholar
• Baekkevold ES, Yamanaka T, Palframan RT, et al. The CCR7 ligand elc (CCL19) is transcytosed in high endothelial venules and mediates T cell recruitment. J Exp Med 2001;193(9):1105-12
   PubMed Web of Science ®Google Scholar
• Bolstad AI, Le Hellard S, Kristjansdottir G, et al. Association between genetic variants in the tumour necrosis factor/lymphotoxin α/lymphotoxin β locus and primary Sjogren’s syndrome in Scandinavian samples. Ann Rheum Dis 2012;71(6):981-8
   PubMed Web of Science ®Google Scholar
• Bombardieri M, Barone F, Humby F, et al. Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialoadenitis and MALT lymphoma in Sjögren’s syndrome. J Immunol 2007;179(7):4929-38
   PubMed Web of Science ®Google Scholar
• Le Pottier L, Devauchelle V, Fautrel A, et al. Ectopic Germinal Centers Are Rare in Sjogren’s Syndrome Salivary Glands and Do Not Exclude Autoreactive B Cells. J Immunol 2009;182(6):3540-7
   PubMed Web of Science ®Google Scholar
• Jonsson MV, Skarstein K, Jonsson R, Brun JG. Serological implications of germinal center-like structures in primary Sjögren’s syndrome. J Rheumatol 2007;34(10):2044-9
   PubMed Web of Science ®Google Scholar
• Rönnblom L, Eloranta M-L. The interferon signature in autoimmune diseases. Curr Opin Rheumatol 2013;25(2):248-53
   PubMed Web of Science ®Google Scholar
• Hjelmervik TOR, Petersen K, Jonassen I, et al. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren’s syndrome patients from healthy control subjects. Arthritis Rheum 2005;52(5):1534-44
   PubMed Web of Science ®Google Scholar
• Gottenberg J-E, Cagnard N, Lucchesi C, et al. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren’s syndrome. Proc Natl Acad Sci USA 2006;103(8):2770-5
   PubMed Web of Science ®Google Scholar
• Siegal FP, Kadowaki N, Shodell M, et al. The nature of the principal type 1 interferon-producing cells in human blood. Science 1999;284(5421):1835-7
   PubMed Web of Science ®Google Scholar
• Zheng L, Zhang Z, Yu C, et al. Association between IFN-alpha and primary Sjogren’s syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;107(1):e12-18
   PubMed Web of Science ®Google Scholar
• Brkic Z, Maria NI, van Helden Meeuwsen CG, et al. Prevalence of interferon type I signature in CD14 monocytes of patients with Sjögren’s syndrome and association with disease activity and BAFF gene expression. Ann Rheum Dis 2013;72(5):728-35
   PubMed Web of Science ®Google Scholar
• Mariette X, Roux S, Zhang J, et al. The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren’s syndrome. Ann Rheum Dis 2003;62(2):168-71
   PubMed Web of Science ®Google Scholar
• Ittah M, Miceli-Richard C, Gottenberg J-E, et al. B-cell-activating factor expressions in salivary epithelial cells after dsRNA virus infection depends on RNA-activated protein kinase activation. Eur J Immunol 2009;39(5):1271-9
   PubMed Web of Science ®Google Scholar
• Miceli-Richard C, Comets E, Loiseau P, et al. Association of an IRF5 gene functional polymorphism with Sjögren’s syndrome. Arthritis Rheum 2007;56(12):3989-94
   PubMedGoogle Scholar
• Gestermann N, Mekinian A, Comets E, et al. STAT4 is a confirmed genetic risk factor for Sjögren’s syndrome and could be involved in type 1 interferon pathway signaling. Genes Immun 2010;11(5):432-8
   PubMed Web of Science ®Google Scholar
• Lessard CJ, Li H, Adrianto I, et al. Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren’s syndrome. Nat Genet 2013;45(11):1284-92
   PubMed Web of Science ®Google Scholar
• Rusakiewicz S, Nocturne G, Lazure T, et al. NCR3/NKp30 Contributes to Pathogenesis in Primary Sjogren’s Syndrome. Sci Transl Med 2013;5(195):195ra96
   PubMed Web of Science ®Google Scholar
• Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004;4(10):757-68
   PubMed Web of Science ®Google Scholar
• Küppers R. B cells under influence: transformation of B cells by Epstein-Barr virus. Nat Rev Immunol 2003;3(10):801-12
   PubMed Web of Science ®Google Scholar
• Thorley-Lawson DA. Epstein-Barr virus: exploiting the immune system. Nat Rev Immunol 2001;1(1):75-82
   PubMed Web of Science ®Google Scholar
• Maeda E, Akahane M, Kiryu S, et al. Spectrum of Epstein-Barr virus-related diseases: a pictorial review. Jpn J Radiol 2009;27(1):4-19
   PubMed Web of Science ®Google Scholar
• Fox RI, Pearson G, Vaughan JH. Detection of Epstein-Barr virus-associated antigens and DNA in salivary gland biopsies from patients with Sjogren’s syndrome. J Immunol 1986;137(10):3162-8
   PubMed Web of Science ®Google Scholar
• Maitland N, Flint S, Scully C, Crean SJ. Detection of cytomegalovirus and Epstein-Barr virus in labial salivary glands in Sjogren’s syndrome and non-specific sialadenitis. J Oral Pathol Med 1995;24(7):293-8
   PubMed Web of Science ®Google Scholar
• Yamaoka K, Miyasaka N, Yamamoto K. Possible involvement of Epstein-Barr virus in polyclonal B cell activation in Sjögren’s syndrome. Arthritis Rheum 1988;31(8):1014-21
   PubMedGoogle Scholar
• Saito I, Servenius B, Compton T, Fox RI. Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren’s syndrome. J Exp Med 1989;169(6):2191-8
   PubMed Web of Science ®Google Scholar
• Wen S, Shimizu N, Yoshiyama H, et al. Association of Epstein-Barr virus (EBV) with Sjögren’s syndrome: differential EBV expression between epithelial cells and lymphocytes in salivary glands. Am J Pathol 1996;149(5):1511
   PubMed Web of Science ®Google Scholar
• Pflugfelder SC, Crouse CA, Atherton SS. Epstein-Barr virus and the lacrimal gland pathology of Sjögren’s syndrome. Adv Exp Med Biol 1994;350:641-6
   PubMedGoogle Scholar
• Mariette X, Gozlan J, Clerc D, et al. Detection of Epstein-Barr virus DNA by in situ hybridization and polymerase chain reaction in salivary gland biopsy specimens from patients with Sjögren’s syndrome. Am J Med 1991;90(3):286-94
   PubMed Web of Science ®Google Scholar
• DiGiuseppe JA, Wu TC, Corio RL. Analysis of Epstein-Barr virus-encoded small RNA 1 expression in benign lymphoepithelial salivary gland lesions. Mod Pathol 1994;7(5):555-9
   PubMed Web of Science ®Google Scholar
• Venables PJ, Teo CG, Baboonian C, et al. Persistence of Epstein-Barr virus in salivary gland biopsies from healthy individuals and patients with Sjögren’s syndrome. Clin Exp Immunol 1989;75(3):359-64
   PubMed Web of Science ®Google Scholar
• Deacon LM, Shattles WG, Mathews JB, et al. Frequency of EBV DNA detection in Sjögren’s syndrome. Am J Med 1992;92(4):453-4
   PubMed Web of Science ®Google Scholar
• Tateishi M, Saito I, Yamamoto K, Miyasaka N. Spontaneous production of Epstein-Barr virus by B lymphoblastoid cell lines obtained from patients with Sjögren’s syndrome. Possible involvement of a novel strain of Epstein-Barr virus in disease pathogenesis. Arthritis Rheum 1993;36(6):827-35
   PubMed Web of Science ®Google Scholar
• Kohm AP, Fuller KG, Miller SD. Mimicking the way to autoimmunity: an evolving theory of sequence and structural homology. Trends Microbiol 2003;11(3):101-5
   PubMed Web of Science ®Google Scholar
• Lerner MR, Andrews NC, Miller G, Steitz JA. Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc Natl Acad Sci USA 1981;78(2):805-9
   PubMed Web of Science ®Google Scholar
• Poole BD, Scofield RH, Harley JB, James JA. Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus. Autoimmunity 2006;39(1):63-70
   PubMed Web of Science ®Google Scholar
• Inoue H, Tsubota K, Ono M, et al. Possible involvement of EBV-mediated alpha-fodrin cleavage for organ-specific autoantigen in Sjogren’s syndrome. J Immunol 2001;166(9):5801-9
   PubMed Web of Science ®Google Scholar
• Haneji N, Nakamura T, Takio K, et al. Identification of alpha-fodrin as a candidate autoantigen in primary Sjögren’s syndrome. Science 1997;276(5312):604-7
   PubMed Web of Science ®Google Scholar
• Navone R, Lunardi C, Gerli R, et al. Identification of tear lipocalin as a novel autoantigen target in Sjögren’s syndrome. J Autoimmun 2005;25(3):229-34
   PubMed Web of Science ®Google Scholar
• Vernant JC, Buisson G, Magdeleine J, et al. T-lymphocyte alveolitis, tropical spastic paresis, and Sjögren syndrome. Lancet 1988;1(8578):177
   PubMed Web of Science ®Google Scholar
• Green JE, Hinrichs SH, Vogel J, Jay G. Exocrinopathy resembling Sjögren’s syndrome in HTLV-1 tax transgenic mice. Nature 1989;341(6237):72-4
   PubMed Web of Science ®Google Scholar
• Eguchi K, Matsuoka N, Ida H, et al. Primary Sjögren’s syndrome with antibodies to HTLV-I: clinical and laboratory features. Ann Rheum Dis 1992;51(6):769-76
   PubMed Web of Science ®Google Scholar
• Shattles WG, Brookes SM, Venables PJ, et al. Expression of antigen reactive with a monoclonal antibody to HTLV-1 P19 in salivary glands in Sjögren’s syndrome. Clin Exp Immunol 1992;89(1):46-51
   PubMed Web of Science ®Google Scholar
• Mariette X, Agbalika F, Daniel MT, et al. Detection of human T lymphotropic virus type I tax gene in salivary gland epithelium from two patients with Sjögren’s syndrome. Arthritis Rheum 1993;36(10):1423-8
   PubMedGoogle Scholar
• Sumida T, Yonaha F, Maeda T, et al. Expression of sequences homologous to HTLV-I tax gene in the labial salivary glands of Japanese patients with Sjögren’s syndrome. Arthritis Rheum 1994;37(4):545-50
   PubMedGoogle Scholar
• Lee SJ, Lee JS, Shin MG, et al. Detection of HTLV-1 in the Labial Salivary Glands of Patients with Sjogren’s Syndrome: a Distinct Clinical Subgroup? J Rheumatol 2012;39(4):809-15
   PubMed Web of Science ®Google Scholar
• Ohyama Y, Nakamura S, Hara H, et al. Accumulation of human T lymphotropic virus type I-infected T cells in the salivary glands of patients with human T lymphotropic virus type I-associated Sjögren’s syndrome. Arthritis Rheum 1998;41(11):1972-8
   PubMed Web of Science ®Google Scholar
• Hida A, Imaizumi M, Sera N, et al. Association of human T lymphotropic virus type I with Sjogren syndrome. Ann Rheum Dis 2010;69(11):2056-7
   PubMed Web of Science ®Google Scholar
• Nelson PN, Lever AM, Bruckner FE, et al. Polymerase chain reaction fails to incriminate exogenous retroviruses HTLV-I and HIV-1 in rheumatological diseases although a minority of sera cross react with retroviral antigens. Ann Rheum Dis 1994;53(11):749-54
   PubMed Web of Science ®Google Scholar
• Triantafyllopoulou A, Moutsopoulos HM. Autoimmunity and coxsackievirus infection in primary Sjogren’s syndrome. Ann N Y Acad Sci 2005;1050:389-96
   PubMed Web of Science ®Google Scholar
• Triantafyllopoulou A, Tapinos N, Moutsopoulos HM. Evidence for coxsackievirus infection in primary Sjögren’s syndrome. Arthritis Rheum 2004;50(9):2897-902
   PubMedGoogle Scholar
• Stathopoulou EA, Routsias JG, Stea EA, et al. Cross-reaction between antibodies to the major epitope of Ro60 kD autoantigen and a homologous peptide of Coxsackie virus 2B protein. Clin Exp Immunol 2005;141(1):148-54
   PubMed Web of Science ®Google Scholar
• Gottenberg J-E, Pallier C, Ittah M, et al. Failure to confirm coxsackievirus infection in primary Sjögren’s syndrome. Arthritis Rheum 2006;54(6):2026-8
   PubMedGoogle Scholar
• Viskari H, Ludvigsson J, Uibo R, et al. Relationship between the incidence of type 1 diabetes and enterovirus infections in different European populations: results from the EPIVIR project. J Med Virol 2004;72(4):610-17
   PubMed Web of Science ®Google Scholar
• Fleck M, Kern ER, Zhou T, et al. Murine cytomegalovirus induces a Sjögren’s syndrome-like disease in C57Bl/6-lpr/lpr mice. Arthritis Rheum 1998;41(12):2175-84
   PubMed Web of Science ®Google Scholar
• Skarstein K, Wahren M, Zaura E, et al. Characterization of T Cell Receptor Repertoire and Anti-Ro/SSA Autoantibodies in Relation to Sialadenitis of NOD Mice. Autoimmunity 1995;22(1):9-16
   PubMed Web of Science ®Google Scholar
• Murakami J, Shimizu Y, Kashii Y, et al. Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C. Hepatology 1999;30(1):143-50
   PubMed Web of Science ®Google Scholar
• Minutello MA, Pileri P, Unutmaz D, et al. Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J Exp Med 1993;178(1):17-25
   PubMed Web of Science ®Google Scholar
• Cerny A, Chisari FV. Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology 1999;30(3):595-601
   PubMed Web of Science ®Google Scholar
• Sansonno D, Tucci FA, Troiani L, et al. Increased serum levels of the chemokine CXCL13 and up-regulation of its gene expression are distinctive features of HCV-related cryoglobulinemia and correlate with active cutaneous vasculitis. Blood 2008;112(5):1620-7
   PubMed Web of Science ®Google Scholar
• Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;554-8
   PubMed Web of Science ®Google Scholar
• Ramos-Casals M, García-Carrasco M, Cervera R, et al. Hepatitis C virus infection mimicking primary Sjögren syndrome. A clinical and immunologic description of 35 cases. Medicine (Baltimore) 2001;80(1):1-8
   PubMed Web of Science ®Google Scholar
• Arrieta JJ, Rodríguez-Iñigo E, Ortiz-Movilla N, et al. In situ detection of hepatitis C virus RNA in salivary glands. Am J Pathol 2001;158(1):259-64
   PubMed Web of Science ®Google Scholar
• Toussirot E, Le Huédé G, Mougin C, et al. Presence of hepatitis C virus RNA in the salivary glands of patients with Sjögren’s syndrome and hepatitis C virus infection. J Rheumatol 2002.29(11): 2382-5
   Google Scholar
• Koike K, Moriya K, Ishibashi K, et al. Expression of hepatitis C virus envelope proteins in transgenic mice. J Gen Virol 1995;76(Pt 12):3031-8
   PubMedGoogle Scholar
• Ramos-Casals M, Loustaud-Ratti V, De Vita S, et al. Sjögren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases. Medicine (Baltimore) 2005;84(2):81-9
   PubMed Web of Science ®Google Scholar
• Tschernig T, Pabst R. Bronchus-Associated Lymphoid Tissue (BALT) Is Not Present in the Normal Adult Lung but in Different Diseases. Pathobiology 2000;68(1):1-8
   PubMed Web of Science ®Google Scholar
• Rangel-Moreno J, Hartson L, Navarro C, et al. Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J Clin Invest 2006;116(12):3183-94
   PubMed Web of Science ®Google Scholar
• Rangel-Moreno J, Moyron-Quiroz JE, Hartson L, et al. Pulmonary expression of CXC chemokine ligand 13, CC chemokine ligand 19, and CC chemokine ligand 21 is essential for local immunity to influenza. Proc Natl Acad Sci USA 2007;104(25):10577-82
   PubMed Web of Science ®Google Scholar
• Lund FE, Partida-Sánchez S, Lee BO, et al. Lymphotoxin-alpha-deficient mice make delayed, but effective, T and B cell responses to influenza. J Immunol 2002;169(9):5236-43
   PubMed Web of Science ®Google Scholar
• Moyron-Quiroz JE, Rangel-Moreno J, Hartson L, et al. Persistence and responsiveness of immunologic memory in the absence of secondary lymphoid organs. Immunity 2006;25(4):643-54
   PubMed Web of Science ®Google Scholar
• Nguyen CQ, Yin H, Lee BH, et al. Pathogenic effect of interleukin-17A in induction of Sjögren’s syndrome-like disease using adenovirus-mediated gene transfer. Arthritis Res Ther 2010;12(6):R220
   PubMed Web of Science ®Google Scholar
• Bombardieri M, Barone F, Lucchesi D, et al. Inducible Tertiary Lymphoid Structures, Autoimmunity, and Exocrine Dysfunction in a Novel Model of Salivary Gland Inflammation in C57BL/6 Mice. J Immunol 2012;189(7):3767-76
   PubMed Web of Science ®Google Scholar
• Campbell AE, Cavanaugh VJ, Slater JS. The salivary glands as a privileged site of cytomegalovirus immune evasion and persistence. Med Microbiol Immunol 2008;197(2):205-13
   PubMed Web of Science ®Google Scholar
• Serafini B, Rosicarelli B, Franciotta D, et al. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 2007;204(12):2899-912
   PubMed Web of Science ®Google Scholar
• Cavalcante P, Serafini B, Rosicarelli B, et al. Epstein-Barr virus persistence and reactivation in myasthenia gravis thymus. Ann Neurol 2010;67(6):726-38
   PubMed Web of Science ®Google Scholar
• Sargsyan SA, Shearer AJ, Ritchie AM, et al. Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis. Neurology 2010;74(14):1127-35
   PubMed Web of Science ®Google Scholar
• Lassmann H, Niedobitek G, Aloisi F, Middeldorp JM. NeuroproMiSe EBV Working Group. Epstein-Barr virus in the multiple sclerosis brain: a controversial issue – report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria. Brain 2011;134(Pt 9):2772-86
   PubMedGoogle Scholar
• Willis SN, Stadelmann C, Rodig SJ, et al. Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain. Brain 2009;132(Pt 12):3318-28
   PubMed Web of Science ®Google Scholar
• Kakalacheva K, Maurer MA, Tackenberg B, et al. Intrathymic Epstein-Barr virus infection is not a prominent feature of myasthenia gravis. Ann Neurol 2011;70(3):508-14
   PubMed Web of Science ®Google Scholar
• Croia C, Serafini B, Bombardieri M, et al. Epstein-Barr virus persistence and infection of autoreactive plasma cells in synovial lymphoid structures in rheumatoid arthritis. Ann Rheum Dis 2013;72(9):1559-68
   PubMed Web of Science ®Google Scholar
• Croia C, Serafini B, Sutcliffe N, et al. Ectopic lymphoid structures support Epstein-Barr virus persistence and autoreactive plasma cell infection in Sjogren’s syndrome salivary glands. European League Against Rheumatism (EULAR) congress, Madrid, Spain: 2013
   Google Scholar
• Farina A, Santarelli R, Gonnella R, et al. The BFRF1 gene of Epstein-Barr virus encodes a novel protein. J Virol 2000;74(7):3235-44
   PubMed Web of Science ®Google Scholar
• Roughan JE, Thorley-Lawson DA. The intersection of Epstein-Barr virus with the germinal center. J Virol 2009;83(8):3968-76
   PubMed Web of Science ®Google Scholar
• Thorley-Lawson DA, Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 2004;350(13):1328-37
   PubMed Web of Science ®Google Scholar
• Pender MP. Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases. Trends Immunol 2003;24(11):584-8
   PubMed Web of Science ®Google Scholar